Skip to content
ppharmaranks
Menu
Bristol Myers Squibb logo

opdivo

Pharmaranks rates Opdivo 3.6/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Opdivo (Nivolumab) is a programmed death receptor-1 blocking antibody used to treat Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Squamous Cell Carcinoma, Kidney Neoplasms.

Nivolumab · by Bristol Myers Squibb

72/100Limited · 1 source

Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate
Verified againstopenFDANIH DailyMedRxClass

Key facts

Active ingredient
Nivolumab
Form
Injectable
Strength
Nivolumab 100MG/10ML · Nivolumab 40MG/4ML
Type
Prescription (Rx)
Brand or generic
Brand-name
FDA application
BLA125527

Storing Opdivo, and how long it keeps

Quoted from this product’s own FDA label. Storage belongs to the product and its device, not to the drug in general — a pen and a tablet of the same medicine are kept completely differently.

  • Discard diluted solution if not used within 8 hours from the time of preparation; or • under refrigeration at 2°C to 8°C (36°F to 46°F) and protected from light for no more than 7 days from the time of preparation to end of infusion.
  • Discard diluted solution if not used within 7 days from the time of preparation.

Drug class

May treat (source: NIH RxClass)

See how Opdivo ranks — best-rated programmed death receptor-1 blocking antibody for:

Dosage forms

Injectable

The forms currently marketed in the U.S., per the FDA National Drug Code Directory.

Ways to save

Ask for the generic

Same active ingredient, far cheaper. Is there a generic? →

Request a 90-day supply

Bulk fills usually lower the per-dose price vs monthly refills.

Use copay cards

Manufacturer copay cards & patient-assistance programs — especially for brand drugs.

Compare alternatives

A same-class option may cost less. See alternatives →

Frequently asked questions

What does Opdivo treat?
Opdivo (Nivolumab) may be used to treat urinary bladder neoplasms, non-small-cell lung carcinoma, squamous cell carcinoma, kidney neoplasms, lymphoma, melanoma, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
How is Opdivo rated?
pharmaranks gives Opdivo a composite score of 3.6 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
Is there a coupon or discount for Opdivo?
pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Opdivo. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
Who makes Opdivo?
Opdivo is marketed by Bristol Myers Squibb. You can see Bristol Myers Squibb's full profile, rating, and other products on pharmaranks.
Is Opdivo a brand-name or generic drug?
Opdivo is a brand-name product with the active ingredient Nivolumab.
Is Opdivo available over the counter?
No. Opdivo is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
What forms does Opdivo come in?
Opdivo is currently marketed as injectable, per the FDA's National Drug Code Directory.
What class of drug is Opdivo?
Opdivo is classified as programmed death receptor-1 blocking antibody, per the FDA's Established Pharmacologic Class.
Is Opdivo FDA-registered?
Opdivo is on record with the U.S. FDA under application number BLA125527. You can verify this on its official FDA label.
Has Opdivo been recalled by the FDA?
Opdivo has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
Is Opdivo safe?
There's no single safe-or-not verdict. pharmaranks gives Opdivo a recall-safety score of 72/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.

Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.

Reviews

No reviews yet. Be the first to write one.

Write a review

Reviews are user opinions, not medical advice. Consult a licensed professional.

People also viewed

Compare Opdivo head-to-head

Identify a pill by its imprint →Check a drug interaction →Drug recalls →

Browse medications A–Z

Research products from A to Z, compare independent ratings, and find alternatives.